Skip to Content
Home | news | Health Care

Health Care

Browse Documents
by Date or Issue:
  • Carter, Bipartisan Members Introduce Legislation Seeking Transparency for Drug Industry Middlemen
    Posted in Press Releases on June 14, 2019 | Preview rr
    Tags: Health Care

    This week, Representatives Roger Marshall, MD (KS-01), Peter Welch (VT-At Large), Earl L. “Buddy” Carter (GA-01), and Vicente Gonzalez (TX-15), introduced H.R. 3223, the Pharmacy Benefit Manger Accountability Study Act of 2019. This bipartisan legislation directs the Government Accountability Office (GAO) to conduct a study on the role pharmaceutical benefit managers (PBMs) play in the drug supply chain and serves as a companion to existing Senate efforts. PBMs are third party administrators tha... Read more

  • Carter: The Bill Doesn't Actually Protect Pre-Existing Conditions
    Posted in Press Releases on May 9, 2019 | Preview rr
    Tags: Health Care

    Congressman Earl L. "Buddy" Carter (R-Ga.) slammed House Democrats today for bringing legislation titled the Protecting Americans with Pre-existing Conditions Act to a vote when the legislation does not address pre-existing conditions. Instead, the legislation would hinder the ability of states to lower premiums for Americans across the country. On the floor, Carter said, "I rise today in opposition to the so-called 'Protecting Americans with Pre-existing Conditions Act.' Mr. Speaker, this is a ... Read more

  • Bipartisan Carter Bill to Increase Transparency in Drug Pricing System Approved by Subcommittee
    Posted in Press Releases on March 27, 2019 | Preview rr
    Tags: Health Care

    Congressman Earl L. "Buddy" Carter's (R-Ga.) bipartisan legislation to increase transparency in the drug pricing system was approved by the House Energy and Commerce Committee's Health Subcommittee today. Currently, Congress’ independent advisory commissions, the Medicare Payment Advisory Commission (MedPAC) and the Medicaid and CHIP Payment and Access Commission (MACPAC), do not have access to certain drug pricing data. MedPAC and MACPAC need data, such as information about drug rebates, in ord... Read more

  • Carter, O’Halleran, Rice, Panetta Introduce Bipartisan Bill to Increase Transparency in the Drug Pricing System
    Posted in Press Releases on March 14, 2019 | Preview rr
    Tags: Health Care

    Today Representative Earl L. “Buddy” Carter (R-Ga.) along with Representatives Tom O’Halleran (D-Az.), Tom Rice (R-Sc.) and Jimmy Panetta (D-Ca.) introduced bipartisan legislation to increase transparency in the drug pricing system. Currently, Congress’ independent advisory commissions, the Medicare Payment Advisory Commission (MedPAC) and the Medicaid and CHIP Payment and Access Commission (MACPAC), do not have access to certain drug pricing data. MedPAC and MACPAC need data such as information... Read more

  • Carter, Schrader Introduce Bipartisan Bill to Keep Drug Costs Down
    Posted in Press Releases on January 31, 2019 | Preview rr
    Tags: Health Care

    Congressman Earl L. "Buddy" Carter (R-Ga.) and Congressman Kurt Schrader (D-Or.) today introduced legislation aimed at keeping drug prices down by increasing competition in the generic drug market. Current law awards 180 days of exclusivity on the market to a drug manufacturer when they are the first to file a generic drug application with the FDA for a drug for which there is no generic. The purpose of this award is to reward manufacturers for challenging weak patents and bringing new low-cost ... Read more

  • Carter Bills to Combat the Opioid Crisis Signed into Law Today
    Posted in Press Releases on October 24, 2018 | Preview rr
    Tags: Health Care

    President Donald Trump today signed into law a bipartisan, bicameral package designed to combat the opioid epidemic. Included in the package are three bills introduced by Congressman Earl L. "Buddy" Carter (R-Ga.) as part of his ongoing efforts to end the epidemic. "I am excited and proud that this package was signed into law today," said Carter. "While working with members on both sides of the aisle to create these solutions to combat this crisis, I learned from constituents, colleagues, and ot... Read more

  • Carter Joins President Trump as "Gag Clause" Prohibition Becomes Law
    Posted in Press Releases on October 10, 2018 | Preview rr
    Tags: Health Care

    Congressman Earl L. "Buddy" Carter (R-Ga.) joined President Donald Trump today at the White House as he signed legislation to prohibit "gag clause" provisions into law. Today, President Trump signed two Senate companion bills to Carter's Know the Cost Act. These bills prohibit "gag clause" provisions in Medicare as well as in group or individual health plans. Rep. Carter joins President Trump at the White House for the signing ceremony of legislation to ban "gag clause" provisions Currently, Pha... Read more

  • Opioid Relief Package Includes Carter Bills to Combat Crisis
    Posted in Press Releases on September 28, 2018 | Preview rr
    Tags: Health Care

    Today the U.S. House of Representatives approved a bipartisan, bicameral opioid package designed to combat the opioid epidemic. Included in the package are three bills introduced by Congressman Earl L. "Buddy" Carter (R-Ga.) as part of his ongoing efforts to end the epidemic. "We are losing 115 Americans every day to the opioid crisis," said Carter. "As a pharmacist, I viewed addressing prescription drug abuse as part of my professional duty and I have continued this work in Congress. I am proud... Read more

  • Carter Applauds House Passage of "Gag Clause" Prohibition
    Posted in Press Releases on September 25, 2018 | Preview rr
    Tags: Health Care

    Congressman Earl L. "Buddy" Carter (R-Ga.) today applauded House passage of legislation to ban "gag clause" provisions. Today, the U.S. House of Representatives approved two Senate companion bills to Carter's Know the Cost Act. These bills prohibit "gag clause" provisions in Medicare as well as in group or individual health plans. Currently, Pharmacy Benefit Managers (PBMs) are able to include requirements in contracts that prevent pharmacists from providing advice to their patients on the best ... Read more

  • Energy and Commerce Committee Approves Carter Legislation to Ban "Gag Clause" Provisions
    Posted in Press Releases on September 13, 2018 | Preview rr
    Tags: Health Care

    The House Energy and Commerce Committee approved Congressman Earl L. "Buddy" Carter's (R-Ga.) legislation today to prohibit "gag clause" provisions. Currently, Pharmacy Benefit Managers (PBMs) are able to include requirements in contracts that prevent pharmacists from providing advice to their patients on the best and cheapest out-of-pocket alternatives to medications covered under insurance. This is commonly known as a "gag clause." As a result, patients may be paying more for their prescriptio... Read more

Back to top